Jason G Umans Selected Research

Doxylamine

11/2016	Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.
1/2016	Effectiveness of doxylamine-pyridoxine for morning sickness.
3/2015	Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.
12/2014	Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.
10/2012	Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy.
12/2010	Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason G Umans Research Topics

Disease

30	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 08/2008
16	Hypertension (High Blood Pressure) 08/2021 - 11/2003
14	Obesity 01/2020 - 12/2006
12	Type 2 Diabetes Mellitus (MODY) 12/2021 - 04/2008
10	Atherosclerosis 01/2022 - 04/2008
10	Albuminuria 01/2017 - 02/2007
8	Neoplasms (Cancer) 01/2022 - 01/2012
6	Prediabetic State (Prediabetes) 12/2021 - 07/2010
6	Insulin Resistance 01/2020 - 04/2012
5	Nausea 11/2016 - 12/2010
5	Vomiting 11/2016 - 12/2010
5	Kidney Diseases (Kidney Disease) 07/2015 - 12/2011
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018 - 02/2012
4	Chronic Renal Insufficiency 07/2015 - 12/2011
3	Inflammation (Inflammations) 01/2017 - 08/2008
3	Stroke (Strokes) 01/2015 - 06/2010
3	Coronary Disease (Coronary Heart Disease) 11/2013 - 08/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2012 - 06/2010
2	Carotid Artery Diseases 01/2017 - 12/2008
2	Thrombosis (Thrombus) 01/2017 - 08/2008
2	Peripheral Arterial Disease 12/2016 - 11/2013
2	Pre-Eclampsia (Preeclampsia) 02/2016 - 04/2011
2	Morning Sickness 01/2016 - 12/2014
2	Gout 07/2014 - 05/2013
2	Hyperuricemia 07/2014 - 05/2013
2	Glucose Intolerance 02/2012 - 07/2010
2	Renal Insufficiency (Renal Failure) 07/2009 - 12/2006
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Emphysema 11/2019
1	Lung Diseases (Lung Disease) 11/2019
1	Surgical Wound Infection 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 03/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Vascular Diseases (Vascular Disease) 01/2017

Drug/Important Bio-Agent (IBA)

21	ArsenicIBA 01/2022 - 01/2012
13	CreatinineIBA 01/2021 - 02/2007
12	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 03/2008
7	LipidsIBA 12/2021 - 10/2009
7	AlbuminsIBA 05/2014 - 02/2007
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2009
6	Pyridoxine (Pyridoxin)FDA LinkGeneric 11/2016 - 12/2010
6	DoxylamineIBA 11/2016 - 12/2010
6	oxidized low density lipoproteinIBA 06/2012 - 04/2008
5	LDL CholesterolIBA 10/2012 - 04/2008
5	SandIBA 11/2011 - 04/2008
4	C-Reactive ProteinIBA 01/2019 - 01/2010
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2013 - 11/2008
3	Insulin (Novolin)FDA Link 01/2020 - 07/2010
3	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 04/2007
3	Drinking WaterIBA 01/2017 - 01/2012
3	MetalsIBA 05/2016 - 05/2013
3	pyridoxine drug combination doxylamine dicyclomine (bendectin)FDA Link 03/2015 - 12/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2015 - 06/2010
3	Uric Acid (Urate)IBA 07/2014 - 02/2012
3	CadmiumIBA 04/2014 - 05/2013
3	Lipoproteins (Lipoprotein)IBA 06/2012 - 10/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2011 - 03/2008
2	Unithiol (DMPS)IBA 01/2022 - 01/2020
2	Vitamin B 6IBA 12/2018 - 12/2014
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 11/2008
2	HDL CholesterolIBA 01/2018 - 01/2017
2	SphingolipidsIBA 01/2018 - 01/2016
2	SteroidsIBA 01/2016 - 01/2012
2	TabletsIBA 03/2015 - 10/2012
2	Angiotensin IIIBA 09/2014 - 11/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 02/2012
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2014 - 11/2012
2	Fibrinogen (Factor I)FDA Link 01/2012 - 08/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2009 - 12/2008
1	SeleniumIBA 11/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 08/2021
1	AcidsIBA 04/2021
1	arsenobetaineIBA 01/2021
1	nasIBA 01/2020
1	MolybdenumIBA 10/2018
1	TungstenIBA 10/2018
1	CPG-oligonucleotideIBA 03/2018
1	VaccinesIBA 03/2018
1	ThymidineIBA 03/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2018
1	PhytohemagglutininsIBA 03/2018
1	B-insulinIBA 01/2018
1	SphingomyelinsIBA 01/2018
1	CeramidesIBA 01/2018
1	CholesterolIBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 11/2016
1	Neuropeptide YIBA 02/2016
1	AmidesIBA 01/2016
1	prenolIBA 01/2016
1	oleoylethanolamideIBA 01/2016

Therapy/Procedure

4	Therapeutics 09/2014 - 12/2005
2	Renal Dialysis (Hemodialysis) 12/2006 - 12/2005
1	Nebulizers and Vaporizers (Inhaler) 01/2022
1	Patient Care Bundles 11/2019
1	Percutaneous Coronary Intervention 01/2017
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017
1	Precision Medicine 11/2016